with regard to clinically attainable concentrations , 98.9 % of the strains were susceptible to gentamicin and tobramycin 97.9 % to amikacin , 96.9 % to colimycin , 88.6 % to piperacillin , 38 % to carbenicillin , 25.7 % to kanamycin , 12.3 % to ampicillin , and 1 % to cephalothin .
C0002499
amikacin
C0022487
kanamycin